Dendritic Cells in Innate Immunity

先天免疫中的树突状细胞

基本信息

  • 批准号:
    7652140
  • 负责人:
  • 金额:
    $ 29.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-15 至 2009-02-28
  • 项目状态:
    已结题

项目摘要

The immune system has evolved different types of immunities, each one specialized for the elimination of particular classes of pathogens. In response to intracellular microbes, CD4+ T-helper (Th) cells differentiate into Thl cells, which produce IFN-y; in contrast, helminths induce the differentiation of Th2 cells, whose cytokines (principally IL-4, IL-5 & ILl0) induce IgE and eosinophil-mediated destruction of the pathogens. While cytokines produced early in the response are crucial in determining the Th polarization of the immune response, the mechanism by which a given pathogen stimulates a particular type of immunity is unknown. Several observations hint at a possible mechanism. First, distinct types of dendritic cell (DC) subsets differentially can induce Thl and Th2 responses. Second, different microbial stimuli signal through distinct pattern recognition receptors on antigen presenting cells (APC). For example, LPS from E.coli signals through the Toll-like receptor 4 (TLR4), while peptidoglycan from Staphylococcus aureus, and zymosan, signal through TLR2. Third, different microbial stimuli differentially activate DCs to elicit distinct classes of immune responses. For example, while E.cofi LPS stimulates IL-12(p70) production by DCs and primes a Thl response, P.gingivafis LPS or schistosome egg antigens (SEA) do not elicit IL-12(p70), and favor Th2 responses. In this context, it is unclear whether signaling through distinct TLRs can elicit different immune responses. Here, we hypothesize that: (i) signaling via different TLRs can evoke qualitatively different types of responses in DCs, which ultimately mediate distinct classes of immune responses; (ii)learning how microbial stimufi manipulate DCs to modulate the immune response will offer valuable lessons to vaccinologists wishing to achieve the same goal These issues will be addressed using highly purified TLR-dependent and TLR-independent microbial stimuli, including E.cofi LPS, different TLR2 stimuli [such as peptidoglycan (PGN), zymosan, the lipopetide STF from M.tubercolosis, and the small synthetic molecules Pam3 Cys, and MALP], the TLR5 stimulus flagellin, the TLR7 stimuli imidazoquinolines, the TLR9 stimulus CpG DNA, and the TLR3 stimulus poly-I-C, as well as classic Th2 inducers such as SEA and filarial proteins. These reagents will be used to probe the immune stimulatory potential of DC subsets from humans and rhesus macaques. Aim 1. To determine the phenotype, function, and major intracellular signaling pathways induced in human DC subsets by specific TLR.dependent and TLR.independent stimufi Aim 2. To determine the types of CD4+ and CD8+ T cell responses stimulated in vitro by human DC$ activated with various TLR.dependent and TLR-independent stimuli _im 3. To determine the phenotype, function and immune stimulatory capacity of DC subsets from rhesus macaques stimulated in vitro with various TLR.dependent and TLR.independent stimufi Thus, this project will generate a knowledge-base about the responsiveness of DCs in humans and macaques to various TLR stimuli. This, together with the in vivo mice studies proposed in Project 2, Program 3, are expected to yield valuable pre-clinical information, as a prelude to the evaluation of such strategies in Phase 1/11clinical trials.
免疫系统已经进化出不同类型的免疫力,每一种都专门用于消除特定的免疫系统。 病原体的种类。响应于细胞内微生物,CD4 + T辅助(Th)细胞分化成Thl细胞, 产生IFN-γ;相反,蠕虫诱导Th2细胞的分化,其细胞因子(主要是IL-4、IL-5和IL 10) 诱导IgE和嗜酸性粒细胞介导的病原体破坏。虽然细胞因子在反应早期产生, 在决定免疫反应的Th极化中是至关重要的, 刺激特定类型的免疫力是未知的。一些观察结果暗示了一种可能的机制。第一,区别 不同类型的树突状细胞(DC)亚群可以不同地诱导Th1和Th2应答。第二,不同的微生物刺激 通过抗原呈递细胞(APC)上不同模式识别受体进行信号传导。例如,来自大肠杆菌的LPS 通过Toll样受体4(TLR4)发出信号,而来自金黄色葡萄球菌的肽聚糖和酵母聚糖发出信号, 通过TLR2。第三,不同的微生物刺激差异激活DC,以引起不同类别的免疫应答。 例如,虽然大肠杆菌LPS刺激DC产生IL-12(p70)并引发Thl应答,但牙龈卟啉单胞菌LPS或 虫卵抗原(SEA)不诱导IL-12(p70),而有利于Th2应答。在这种情况下,不清楚是否 通过不同TLR的信号传导可引发不同的免疫应答。在这里,我们假设:(i)通过 不同的TLR可以在DC中引起不同类型的反应,其最终介导不同的免疫应答。 免疫反应的类别;(ii)了解微生物刺激如何操纵DC来调节免疫反应。 反应将为希望实现同样目标的疫苗学家提供宝贵的经验教训。 使用高度纯化的TLR依赖性和TLR非依赖性微生物刺激物,包括大肠杆菌LPS, TLR2刺激物[如肽聚糖(PGN)、酵母聚糖、来自结核分枝杆菌的脂肽STF和小的合成的TLR2刺激物]。 分子Pam3 Cys和MALP]、TLR5刺激鞭毛蛋白、TLR7刺激咪唑并喹啉、TLR9刺激 CpG DNA和TLR3刺激多聚-I-C,以及经典的Th2诱导物如SEA和丝虫蛋白。这些 试剂将用于探测来自人和恒河猴的DC亚群的免疫刺激潜力。 目标1.确定人DC诱导的表型、功能和主要的细胞内信号通路 特异性TLR依赖性和TLR非依赖性刺激的亚群 目标2.目的探讨人DC活化后体外刺激的CD4+和CD8 + T细胞应答的类型。 各种TLR依赖性和TLR非依赖性刺激 _im 3.研究恒河猴DC的表型、功能和免疫刺激活性 用各种TLR依赖性和TLR非依赖性刺激体外刺激猕猴, 因此,该项目将产生关于人类和猕猴中DC对以下物质的反应性的知识库: 各种TLR刺激。这与项目2,项目3中提出的体内小鼠研究一起,预计将产生 有价值的临床前信息,作为在I/II期临床试验中评价此类策略的前奏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BALI PULENDRAN其他文献

BALI PULENDRAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BALI PULENDRAN', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10584554
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Project 2: Innate Immunity
项目2:先天免疫
  • 批准号:
    10674303
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
ADJUVANT COMPARISON AND CHARACTERIZATION
佐剂比较和表征
  • 批准号:
    10703849
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Project 3: Mechanistic studies and comparisons of vaccines in preclinical models
项目3:临床前模型中疫苗的机理研究和比较
  • 批准号:
    10425032
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10419276
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Adjuvant Comparison and Characterization (HIV)
佐剂比较和表征(HIV)
  • 批准号:
    10834856
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Systems biological assessment of innate responses to vaccination
对疫苗接种先天反应的系统生物学评估
  • 批准号:
    10584566
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Systems biological assessment of innate and adaptive immunity to vaccination
对疫苗接种的先天性和适应性免疫的系统生物学评估
  • 批准号:
    10419275
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
ADJUVANT COMPARISON AND CHARACTERIZATION
佐剂比较和表征
  • 批准号:
    10830900
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
Systems biological assessment of innate responses to vaccination
对疫苗接种先天反应的系统生物学评估
  • 批准号:
    10419279
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 29.3万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 29.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了